David W. Wray, PhD

phase_1

Exercise Rehabilitation

not_applicable

Atorvastatin

phase_1

BQ-123

early_phase_1

Antioxidant

early_phase_1

Tetrahydrobiopterin (BH4)

early_phase_1

BH4

phase_1

PB125

not_applicable

Improving Exercise Rehabilitation Efficacy Outcomes Veterans Peripheral Artery Disease

+1 more interventions

9 unique interventions3 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed2

Recruiting1

Other1

Role Distribution

Principal Investigator4

PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT05648630Not ApplicableWithdrawn

Inflammation (D007249)Oxidative Stress (D018384)Peripheral Artery Disease (D058729)

PrincipalinvestigatorStart date: 2023-07-03

NCT06312748Phase 1Recruiting

Novel Approaches for Improving Vascular Function in Veterans With HFpEF

Heart Failure With Preserved Ejection FractionInflammation

PrincipalinvestigatorStart date: 2021-05-19

NCT03136029Early Phase 1Completed

Exercise and NO in HFrEF

Heart Failure With Reduced Ejection Fraction

PrincipalinvestigatorStart date: 2018-06-01

NCT02124824Early Phase 1Completed

Contribution of Endothelin-1 to Exercise Intolerance in Heart Failure

Heart Failure

PrincipalinvestigatorStart date: 2014-09-01

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Heart Failure1 Heart Failure With Preserved Ejection Fraction1 Heart Failure With Reduced Ejection Fraction1 Inflammation1 Inflammation (D007249)1 Oxidative Stress (D018384)1 Peripheral Artery Disease (D058729)1

Affiliations

VA Salt Lake City Health Care System, Salt Lake City, UT

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

51 trials

Shared therapeutic areas:

Heart FailureHeart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection Fraction

Similarity Score13%

Joo Myung Lee, MD, MPH, PhD

Samsung Medical Center

17 trials

Shared therapeutic areas:

Heart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection Fraction

Similarity Score9%

Shao-Liang Chen, MD

Nanjing First Hospital, Nanjing Medical University

9 trials

Shared therapeutic areas:

Heart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection Fraction

Similarity Score9%

Dusan Kocovic, MD

Main Line Health Center/Lankenau Hospital, Wynnewood, PA

Shared therapeutic areas:

Lawrence Czer, MD

Cedars-Sinai Medical Center, Los Angeles, CA

Shared therapeutic areas:

Joseph Rogers, MD

Duke University Medical Center, Durham, NC

Shared therapeutic areas:

Daniel Landa, MD

St. Jude Hospital, Fullerton, CA

Shared therapeutic areas:

Hamid Gourabi, PhD

head of Royan Institute

52 trials

Shared therapeutic areas:

Zhaoping Li, MD, PhD

University of California, Los Angeles

17 trials

Shared therapeutic areas:

Inflammation

Zi-Juan Xu, MD

Sutter Memorial Hospital, Sacramento, CA

Shared therapeutic areas: